Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Low paediatric tuberculosis case detection rate in Southern Mozambique

Elisa López-Varela, Orvalho Joaquim Augusto, Luis Guerra, Durval Respeito, Charfudin Sacoor, Jahit Sacarlal, Giovanni Battista Migliori, Giovanni Sotgiu, Pedro L. Alonso, Alberto L. García-Basteiro
European Respiratory Journal 2016 47: 1003-1005; DOI: 10.1183/13993003.01454-2015
Elisa López-Varela
1Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
2Instituto de Salud Global de Barcelona (ISGLOBAL), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: elisa.lopez@manhica.net
Orvalho Joaquim Augusto
1Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Guerra
1Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Durval Respeito
1Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charfudin Sacoor
1Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jahit Sacarlal
1Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Battista Migliori
3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Sotgiu
4Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro L. Alonso
1Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
2Instituto de Salud Global de Barcelona (ISGLOBAL), Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto L. García-Basteiro
1Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
2Instituto de Salud Global de Barcelona (ISGLOBAL), Barcelona, Spain
5Amsterdam Institute for Global Health and Development, Academic Medical Centre, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

In this study, the case detection rate of TB in children <3 years in Manhiça, Mozambique was estimated to be 40.8% http://ow.ly/UQg0g

To the Editor:

Two core indicators adopted for evaluating tuberculosis (TB) control programmes are treatment outcome and case detection rate (CDR). While the former is easy to report, the CDR can only be estimated (calculated as notifications of new and relapse cases divided by estimated incidence). According to the World Health Organization (WHO), Mozambique has one of the lowest CDRs among the high TB burden countries (HBCs), with 37% in 2013 [1]. In children, calculating CDR is even more challenging, given the difficulty in diagnosing TB and the lack of accurate estimates for paediatric incidence [2]. Several paediatric TB incidence estimates have been published recently [3–5], showing higher figures than those provided by WHO. The large variation in estimates and the lack of population-based data from HBCs (particularly from Sub-Saharan Africa) highlights the urgent need for new data to inform predictive models necessary to implement the “End TB Strategy” and achieve elimination [6]. The objective of this study was to calculate the paediatric CDR in Mozambique and to provide reference methodology and evidence for other countries.

The study was conducted in the Manhiça District, a high TB-HIV burden district in southern Mozambique [7], where the Manhiça Health Research Centre runs a health and demographic surveillance system (HDSS) [8]. It was a retrospective, population-based analysis, which estimated the TB CDR by comparing the routine TB incidence rate in children aged <3 years reported in the district between 2006 and 2010 with the incidence rate in the study area computed during a prospective study (the ITACA study: determination of the minimum incidence rate of tuberculosis in infants and children in the Manhiça District, Mozambique; October 2011–October 2012) [9]. The latter was considered as the “most accurate incidence rate estimate” available. Prior to the ITACA study, no routine active case finding was performed and bacteriological confirmation was mostly based on smear microscopy. During the ITACA period, all presumptive TB cases were identified through an active and passive case detection system. Children with TB-related symptoms and close contact with a sputum smear-positive TB patient were evaluated through physical and radiological examination, HIV and tuberculin skin testing, as well as smear microscopy and culture of both induced sputum and gastric aspirate samples [9, 10]. For the purpose of this analysis, TB cases were defined as those who started anti-TB treatment. Relapse patients were included.

We calculated the TB incidence rate during the ITACA period as the number of cases in the HDSS area divided by the mid-year population at risk. Pre-ITACA incidence rates were calculated yearly using the number of TB cases in the whole district divided by the district mid-year population, using the Mozambican National Statistics Institute (INE) latest official census data (2007) and taking into account the estimated age-specific population growth for the whole period. Yearly confidence intervals were calculated assuming a Poisson distribution. A pooled incidence rate was calculated for the pre-ITACA period using a weighting scheme through a Poisson regression with random effects and jackknife 95% CI. According to the 2000–2013 WHO data, there has been a slight increase in incidence during this time-frame in Mozambique (figure 1) [1]. Using a log-linear regression and WHO data, we estimated an overall 0.6% yearly increasing trend in TB incidence rate and applied this correction factor to the final CDR to mitigate overestimation.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Yearly tuberculosis incidence rate in the population aged <3 years in the Manhiça District. World Health Organization (WHO) estimates for all-age incidence rate and case detection rate for Mozambique are shown for the pre-ITACA period. ITACA: study for determination of the minimum incidence rate of tuberculosis in infants and children in the Manhiça District, Mozambique; October 2011–October 2012.

A total of 217 TB cases aged <3 years were diagnosed in the pre-ITACA period (2006–2010), with a pooled incidence rate of 251 per 100 000 people (95% CI 227–276 per 100 000). During ITACA, 57 TB cases aged <3 years initiated anti-TB treatment in the HDSS area, equivalent to an incidence rate of 615 per 100 000 people (95% CI 466–797 per 100 000 people) (figure 1). The estimated CDR was 40.8% (95% CI 36.6–45.1%), and 41.8% (95% CI 37.2–46.4%) after correction. In the hypothetical case of a 5% increase in the national incidence, sensitivity analysis showed that the CDR would increase to (49.1%; 95% CI 41.3–57.0%).

The HIV prevalence among the study population was 47% and 46% during the pre-ITACA and ITACA periods, respectively. During the ITACA period, fewer patients aged <1 year initiated anti-TB treatment (8.8% versus 35.9%), more TB cases were extrapulmonary (12.3% versus 7.4%) and the treatment success rate was significantly better (82.5% versus 67.3%; p=0.025).

To our knowledge, this is the first study providing estimates of TB under-detection using population-based data in the paediatric population in Africa and one of the few worldwide. We found a low CDR regardless of age and sex, which underscores the urgent need to close the gap in case detection and reporting, in order to better assess new control interventions [6, 11].

Our findings are in line with the low CDR for Mozambique reported by WHO [1]; however, the rate we report is probably a maximum, given that the ITACA incidence rate is a conservative estimate (single-day samples were obtained in contrast to the recommended 3-day consecutive sampling; contact tracing could not be fully implemented mainly due to difficulties in patient identification; and some TB cases could have been missed due to mortality prior to treatment initiation or transfers of severely ill patients to the tertiary reference hospital) [9].

The CDR higher than the 35% estimated by Dodd et al. [5] for children aged <15 years in all HBCs (based on mathematical modelling of 2010 data) could be due to several reasons.

Given that Mozambique has one of the lowest CDRs among all HBCs and that under-estimation is more frequent in children aged <5 years, the difference observed between our CDR and the one reported by Dodd et al. [5] could support the hypothesis that the true CDR in Manhiça is probably lower than 40.8%. Besides, TB incidence and CDR vary greatly across countries and regions (depending on the local epidemiology of TB/HIV and healthcare system characteristics, among others) and Manhiça could show an improved CDR compared with other settings.

Although under-ascertainment, under-reporting and under-diagnosis can all contribute to TB under-estimation [12], the latter is the most probable in Mozambique, where broad paediatric TB case definitions, lack of clear clinical algorithms, low referral rates and difficulties in obtaining samples all contribute to under-diagnosis. Under-reporting is not common, as the private sector has a small role in TB diagnosis and management. Under-ascertainment alone, although common in Manhiça, cannot explain the low CDR, given the small impact of the active case-finding component of this study.

This study has several limitations. First, the use of a historical control for the calculation of CDR may be imperfect as the incidence rate and CDR vary over time. Although we expected that the 0.6% yearly correction could compensate, we acknowledge that the extent of increase in incidence reported for adults may not be the same for children aged <3 years. Furthermore, we compared incidence rates calculated with different denominators (the intervention HDSS population, based on real annual census data for a smaller urban-shaped area versus the whole district population, based on projections from the INE 2007 census and considering age-specific annual population growth). We did, however, verify that the CDR did not vary substantially when we calculated the ITACA incidence based on INE district data (and using as denominator the percentage of the INE population belonging to HDSS).

This study provides a novel population-based CDR for paediatric TB in a HBC. Although this estimate is probably a maximum, differences in local detection rates can explain a higher CDR than those reported by others [1, 5]. Given the multiple downstream ramifications of inaccurate estimates [13] and the high mortality of undiagnosed TB in younger children [14], this finding calls for urgent public health interventions to ensure that all TB cases are promptly identified and treated.

Acknowledgements

The authors thank the participants and their families. The authors are grateful to the National TB Program (Maputo, Mozambique), Denise Naniche (ISGLOBAL, Barcelona, Spain), Alberto Bila Junior (CISM, Manhiça, Mozambique), health staff at the Manhiça District Hospital (Manhiça, Mozambique) and peripheral health centres for their contribution.

Footnotes

  • Conflict of interest: None declared.

  • Received September 1, 2015.
  • Accepted November 9, 2015.
  • Copyright ©ERS 2016

References

  1. ↵
    World Health Organization. Global Tuberculosis Report 2014. WHO/HTM/TB/2014.08. Geneva, World Health Organization, 2014. Available from: http://www.who.int/tb/publications/global_report/gtbr14_main_text.pdf
  2. ↵
    1. Marais BJ,
    2. Graham SM,
    3. Maeurer M, et al.
    Progress and challenges in childhood tuberculosis. Lancet Infect Dis 2013; 13: 287–289.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Murray CJ,
    2. Ortblad KF,
    3. Guinovart C, et al.
    Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 1005–1070.
    OpenUrlCrossRefPubMedWeb of Science
    1. Jenkins HE,
    2. Tolman AW,
    3. Yuen CM, et al.
    Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014; 383: 1572–1579.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Dodd PJ,
    2. Gardiner E,
    3. Coghlan R, et al.
    Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health 2014; 2: e453–e459.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Lönnroth K,
    2. Migliori GB,
    3. Abubakar I, et al.
    Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 2015; 45: 928–952.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. García-Basteiro AL,
    2. López-Varela E,
    3. Respeito D, et al.
    High tuberculosis burden among people living with HIV in southern Mozambique. Eur Respir J 2015; 45: 547–549.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Sacoor C,
    2. Nhacolo A,
    3. Nhalungo D, et al.
    Profile: Manhiça Health Research Centre (Manhiça HDSS). Int J Epidemiol 2013; 42: 1309–1318.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. López-Varela E,
    2. Augusto OJ,
    3. Gondo K, et al.
    Incidence of tuberculosis among young children in rural Mozambique. Pediatr Infect Dis J 2015; 34: 686–692.
    OpenUrlCrossRefPubMed
  9. ↵
    1. García-Basteiro AL,
    2. López-Varela E,
    3. Augusto OJ, et al.
    Radiological findings in young children investigated for tuberculosis in Mozambique. PLoS One 2015; 10: e0127323.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Rudolf F,
    2. Wejse C
    . Tuberculosis case detection revisited: better testing might not improve outcomes. Lancet Glob Health 2015; 3: e424–e425.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Gibbons CL,
    2. Mangen MJ,
    3. Plass D, et al.
    Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods. BMC Public Health 2014; 14: 147.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Cruz AT,
    2. Starke JR
    . What's in a number? Accurate estimates of childhood tuberculosis. Lancet Glob Health 2014; 2: e432–e433.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Perez-Velez CM,
    2. Marais BJ
    . Tuberculosis in children. N Engl J Med 2012; 367: 348–361.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
View this article with LENS
Vol 47 Issue 3 Table of Contents
European Respiratory Journal: 47 (3)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Low paediatric tuberculosis case detection rate in Southern Mozambique
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Low paediatric tuberculosis case detection rate in Southern Mozambique
Elisa López-Varela, Orvalho Joaquim Augusto, Luis Guerra, Durval Respeito, Charfudin Sacoor, Jahit Sacarlal, Giovanni Battista Migliori, Giovanni Sotgiu, Pedro L. Alonso, Alberto L. García-Basteiro
European Respiratory Journal Mar 2016, 47 (3) 1003-1005; DOI: 10.1183/13993003.01454-2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Low paediatric tuberculosis case detection rate in Southern Mozambique
Elisa López-Varela, Orvalho Joaquim Augusto, Luis Guerra, Durval Respeito, Charfudin Sacoor, Jahit Sacarlal, Giovanni Battista Migliori, Giovanni Sotgiu, Pedro L. Alonso, Alberto L. García-Basteiro
European Respiratory Journal Mar 2016, 47 (3) 1003-1005; DOI: 10.1183/13993003.01454-2015
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Research letters

  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society